NF-kB is a switch in myeloma cells and bone marrow promoting their growth in spite of conventional treatments. In this study, I will use PS-1145 to specifically turn this switch off in laboratory and animal studies of human multiple myeloma growth. These studies will provide the basis for clinical trials of PS-1145 in multiple myeloma.